Four Thought Financial, LLC Deciphera Pharmaceuticals, Inc. Transaction History

Four Thought Financial, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 14, 2022	SELL	$7.7 - $37.13 $7,415 - $35,756	-963 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$26.46 - $37.15 $264 - $371	10 Added 1.05%	963 $32,000
Q2 2021 Nov 12, 2021	SELL	$32.73 - $47.95 $523 - $767	-16 Reduced 1.65%	953 $34,000
Q1 2021 Nov 12, 2021	SELL	$40.39 - $56.73 $2,908 - $4,084	-72 Reduced 6.92%	969 $43,000
Q4 2020 Nov 12, 2021	BUY	$51.77 - $66.18 $53,892 - $68,893	1,041 New	1,041 $59,000

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Four Thought Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Four Thought Financial, LLC with notifications on news.